La M. Rouge
Rennes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics, and pharmacodynamics of OSE-279, an anti-PD-1 monoclonal antibody in patients with advanced solid tumours.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 02, 2026
Role of platinum-free interval (PFI) and maintenance therapies in recurrent ovarian cancer to explain survival. An analysis from the French real-world ESME Ovarian Database.
Journal: Gynecologic oncology
Published: March 18, 2025
Tumor-intrinsic chemosensitivity assessed by KELIM and prognosis by BRCA status in patients with advanced ovarian carcinomas.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: June 29, 2024
Consensus on drivers of maintenance treatment choice and patterns of care in advanced ovarian cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: March 20, 2024
Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salomé study including 469 patients. A TMRG and GINECO group study.
Journal: Gynecologic oncology
Published: December 14, 2022
Optimal timing of interval debulking surgery for advanced epithelial ovarian cancer: A retrospective study from the ESME national cohort.
Journal: Gynecologic oncology
Published: June 18, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026